Acasti Pharma Inc. Share Price Toronto S.E.
Equities
ACST
CA00430K8730
Pharmaceuticals
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 37.31M 27.28M 2.19B |
---|---|---|---|---|---|
Net income 2024 * | -18M -13.16M -1.05B | Net income 2025 * | -23M -16.81M -1.35B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.05
x | P/E ratio 2025 * |
-2.64
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.98% |
Latest transcript on Acasti Pharma Inc.
Managers | Title | Age | Since |
---|---|---|---|
Prashant Kohli
CEO | Chief Executive Officer | 52 | 31/07/21 |
Director of Finance/CFO | 52 | 01-04 | |
Carrie D'Andrea
CTO | Chief Tech/Sci/R&D Officer | 52 | 07/05/23 |
Members of the board | Title | Age | Since |
---|---|---|---|
A. Davis
BRD | Director/Board Member | 57 | 09/10/23 |
Director/Board Member | - | 09/10/23 | |
Santosh Kottayil
BRD | Director/Board Member | - | 09/10/23 |
1st Jan change | Capi. | |
---|---|---|
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |